S&P 500   3,689.44 (+0.62%)
DOW   30,123.82 (+0.51%)
QQQ   304.81 (+0.17%)
AAPL   121.77 (-0.95%)
MSFT   214.40 (+0.07%)
FB   280.37 (-0.53%)
GOOGL   1,820.16 (-0.09%)
AMZN   3,166.54 (-0.63%)
TSLA   590.98 (-0.40%)
NVDA   538.72 (+0.54%)
BABA   267.32 (+0.15%)
CGC   28.94 (+1.08%)
GE   10.67 (+0.66%)
MU   73.78 (+5.55%)
AMD   93.25 (+1.02%)
T   29.68 (+1.54%)
NIO   42.42 (-6.46%)
F   9.40 (+2.06%)
ACB   11.78 (+4.80%)
BA   234.71 (-1.05%)
NFLX   499.30 (+0.36%)
GILD   61.29 (+0.71%)
DIS   153.65 (+0.27%)
S&P 500   3,689.44 (+0.62%)
DOW   30,123.82 (+0.51%)
QQQ   304.81 (+0.17%)
AAPL   121.77 (-0.95%)
MSFT   214.40 (+0.07%)
FB   280.37 (-0.53%)
GOOGL   1,820.16 (-0.09%)
AMZN   3,166.54 (-0.63%)
TSLA   590.98 (-0.40%)
NVDA   538.72 (+0.54%)
BABA   267.32 (+0.15%)
CGC   28.94 (+1.08%)
GE   10.67 (+0.66%)
MU   73.78 (+5.55%)
AMD   93.25 (+1.02%)
T   29.68 (+1.54%)
NIO   42.42 (-6.46%)
F   9.40 (+2.06%)
ACB   11.78 (+4.80%)
BA   234.71 (-1.05%)
NFLX   499.30 (+0.36%)
GILD   61.29 (+0.71%)
DIS   153.65 (+0.27%)
S&P 500   3,689.44 (+0.62%)
DOW   30,123.82 (+0.51%)
QQQ   304.81 (+0.17%)
AAPL   121.77 (-0.95%)
MSFT   214.40 (+0.07%)
FB   280.37 (-0.53%)
GOOGL   1,820.16 (-0.09%)
AMZN   3,166.54 (-0.63%)
TSLA   590.98 (-0.40%)
NVDA   538.72 (+0.54%)
BABA   267.32 (+0.15%)
CGC   28.94 (+1.08%)
GE   10.67 (+0.66%)
MU   73.78 (+5.55%)
AMD   93.25 (+1.02%)
T   29.68 (+1.54%)
NIO   42.42 (-6.46%)
F   9.40 (+2.06%)
ACB   11.78 (+4.80%)
BA   234.71 (-1.05%)
NFLX   499.30 (+0.36%)
GILD   61.29 (+0.71%)
DIS   153.65 (+0.27%)
S&P 500   3,689.44 (+0.62%)
DOW   30,123.82 (+0.51%)
QQQ   304.81 (+0.17%)
AAPL   121.77 (-0.95%)
MSFT   214.40 (+0.07%)
FB   280.37 (-0.53%)
GOOGL   1,820.16 (-0.09%)
AMZN   3,166.54 (-0.63%)
TSLA   590.98 (-0.40%)
NVDA   538.72 (+0.54%)
BABA   267.32 (+0.15%)
CGC   28.94 (+1.08%)
GE   10.67 (+0.66%)
MU   73.78 (+5.55%)
AMD   93.25 (+1.02%)
T   29.68 (+1.54%)
NIO   42.42 (-6.46%)
F   9.40 (+2.06%)
ACB   11.78 (+4.80%)
BA   234.71 (-1.05%)
NFLX   499.30 (+0.36%)
GILD   61.29 (+0.71%)
DIS   153.65 (+0.27%)
Log in
NASDAQ:KURA

Kura Oncology News Headlines

$34.69
+0.64 (+1.88 %)
(As of 12/4/2020 11:09 AM ET)
Add
Compare
Today's Range
$33.62
Now: $34.69
$34.92
50-Day Range
$29.00
MA: $34.82
$40.07
52-Week Range
$6.35
Now: $34.69
$40.62
Volume5,209 shs
Average Volume583,552 shs
Market Capitalization$1.97 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.31

Headlines

Kura Oncology (NASDAQ KURA) News Headlines Today

Source:
SourceHeadline
Kura Oncology (NASDAQ:KURA) Downgraded by Zacks Investment ResearchKura Oncology (NASDAQ:KURA) Downgraded by Zacks Investment Research
marketbeat.com - November 17 at 3:34 AM
Kura Oncology (NASDAQ:KURA) Price Target Raised to $37.00 at BarclaysKura Oncology (NASDAQ:KURA) Price Target Raised to $37.00 at Barclays
marketbeat.com - September 30 at 7:33 AM
Kura Oncology (NASDAQ:KURA) Price Target Raised to $32.00 at BarclaysKura Oncology (NASDAQ:KURA) Price Target Raised to $32.00 at Barclays
marketbeat.com - August 31 at 7:29 AM
Brookline Capital Management Reiterates "Buy" Rating for Kura Oncology (NASDAQ:KURA)Brookline Capital Management Reiterates "Buy" Rating for Kura Oncology (NASDAQ:KURA)
marketbeat.com - August 19 at 7:16 AM
Kura Oncology (NASDAQ:KURA) Coverage Initiated at Stifel NicolausKura Oncology (NASDAQ:KURA) Coverage Initiated at Stifel Nicolaus
americanbankingnews.com - December 2 at 6:18 PM
Kura Oncology (NASDAQ:KURA) Stock Price Down 6.1%Kura Oncology (NASDAQ:KURA) Stock Price Down 6.1%
americanbankingnews.com - December 1 at 8:46 PM
Investors Purchase High Volume of Put Options on Kura Oncology (NASDAQ:KURA)Investors Purchase High Volume of Put Options on Kura Oncology (NASDAQ:KURA)
americanbankingnews.com - December 1 at 10:04 AM
Kura Oncology to Host Virtual Investor Event on December 5, 2020Kura Oncology to Host Virtual Investor Event on December 5, 2020
finance.yahoo.com - November 24 at 7:36 AM
Kura Oncology (NASDAQ:KURA) Stock Price Down 6.3%Kura Oncology (NASDAQ:KURA) Stock Price Down 6.3%
americanbankingnews.com - November 18 at 7:36 PM
Kathleen Ford Sells 6,250 Shares of Kura Oncology, Inc. (NASDAQ:KURA) StockKathleen Ford Sells 6,250 Shares of Kura Oncology, Inc. (NASDAQ:KURA) Stock
americanbankingnews.com - November 12 at 5:57 PM
Kura Oncology (NASDAQ:KURA) Reaches New 1-Year High at $40.00Kura Oncology (NASDAQ:KURA) Reaches New 1-Year High at $40.00
americanbankingnews.com - November 11 at 11:34 AM
Kura Oncology (NASDAQ:KURA) Shares Up 5.6%Kura Oncology (NASDAQ:KURA) Shares Up 5.6%
americanbankingnews.com - November 10 at 5:34 AM
Kura Oncology, Inc. (KURA) CEO Troy Wilson on Q3 2020 Results - Earnings Call TranscriptKura Oncology, Inc. (KURA) CEO Troy Wilson on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 7 at 5:15 PM
Kura Oncology, Inc. (KURA) Q3 2020 Earnings Call TranscriptKura Oncology, Inc. (KURA) Q3 2020 Earnings Call Transcript
finance.yahoo.com - November 7 at 7:11 AM
Kura Oncology EPS misses by $0.03Kura Oncology EPS misses by $0.03
seekingalpha.com - November 5 at 10:00 AM
Kura Oncology, Inc. to Host Earnings CallKura Oncology, Inc. to Host Earnings Call
finance.yahoo.com - November 5 at 10:00 AM
Kura Oncology Reports Third Quarter 2020 Financial ResultsKura Oncology Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 5 at 10:00 AM
Vertex Ventures HC Announces the Addition of George Golumbeski, PhD and Faheem Hasnain as Executive AdvisorsVertex Ventures HC Announces the Addition of George Golumbeski, PhD and Faheem Hasnain as Executive Advisors
prnewswire.com - October 31 at 8:14 AM
Kura Oncology to Report Third Quarter 2020 Financial ResultsKura Oncology to Report Third Quarter 2020 Financial Results
finance.yahoo.com - October 29 at 8:38 AM
Kura Oncology Reports Preclinical Results Showing Antitumor Activity of Tipifarnib in Combination with PI3Kα Inhibitor in Head and Neck Squamous Cell CarcinomaKura Oncology Reports Preclinical Results Showing Antitumor Activity of Tipifarnib in Combination with PI3Kα Inhibitor in Head and Neck Squamous Cell Carcinoma
finance.yahoo.com - October 26 at 12:32 PM
Kura Oncology IncKura Oncology Inc
bloomberg.com - October 24 at 6:27 PM
Kura Oncology Inc (KURA) President and CEO Troy Edward Wilson Sold $3.4 million of SharesKura Oncology Inc (KURA) President and CEO Troy Edward Wilson Sold $3.4 million of Shares
finance.yahoo.com - September 16 at 2:34 AM
Hedge Funds Never Been This Bullish On Kura Oncology, Inc. (KURA)Hedge Funds Never Been This Bullish On Kura Oncology, Inc. (KURA)
finance.yahoo.com - September 15 at 12:35 AM
Kura Oncology to Participate in Two Upcoming Investor ConferencesKura Oncology to Participate in Two Upcoming Investor Conferences
finance.yahoo.com - September 8 at 8:28 AM
Kura Oncology (KURA) Looks Good: Stock Adds 6.8% in SessionKura Oncology (KURA) Looks Good: Stock Adds 6.8% in Session
finance.yahoo.com - August 26 at 10:38 AM
Kura Oncology Appoints Dr. Stephen Dale as Chief Medical OfficerKura Oncology Appoints Dr. Stephen Dale as Chief Medical Officer
finance.yahoo.com - August 25 at 8:25 AM
Looking Under The Covers At Kura OncologyLooking Under The Covers At Kura Oncology
seekingalpha.com - August 13 at 3:00 PM
Kura Oncology, Inc. (KURA) CEO Troy Wilson on Q2 2020 Results - Earnings Call TranscriptKura Oncology, Inc. (KURA) CEO Troy Wilson on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 9 at 5:58 PM
Kura Oncology, Inc. (KURA) Q2 2020 Earnings Call TranscriptKura Oncology, Inc. (KURA) Q2 2020 Earnings Call Transcript
nasdaq.com - August 7 at 6:17 PM
Kura Oncology Reports Second Quarter 2020 Financial ResultsKura Oncology Reports Second Quarter 2020 Financial Results
finance.yahoo.com - August 7 at 1:01 AM
Kura Oncology Reports Second Quarter 2020 Financial ResultsKura Oncology Reports Second Quarter 2020 Financial Results
finance.yahoo.com - August 6 at 8:01 PM
Kura Oncology to Present at Wedbush PacGrow Healthcare Virtual ConferenceKura Oncology to Present at Wedbush PacGrow Healthcare Virtual Conference
finance.yahoo.com - August 4 at 7:36 AM
Kura Oncology to Report Second Quarter 2020 Financial ResultsKura Oncology to Report Second Quarter 2020 Financial Results
www.benzinga.com - July 30 at 9:42 AM
Kura Oncology to Report Second Quarter 2020 Financial ResultsKura Oncology to Report Second Quarter 2020 Financial Results
finance.yahoo.com - July 30 at 9:42 AM
How Many Kura Oncology, Inc. (NASDAQ:KURA) Shares Do Institutions Own?How Many Kura Oncology, Inc. (NASDAQ:KURA) Shares Do Institutions Own?
finance.yahoo.com - July 29 at 1:46 PM
Kura Oncology Inc. Registered S (KUR.SG)Kura Oncology Inc. Registered S (KUR.SG)
au.finance.yahoo.com - July 26 at 5:41 PM
Kura Oncology Presents Preclinical Data Demonstrating Significant Anti-Tumor Activity of KO-947 and KO-539Kura Oncology Presents Preclinical Data Demonstrating Significant Anti-Tumor Activity of KO-947 and KO-539
www.bloomberg.com - July 17 at 1:18 PM
Did Hedge Funds Make The Right Call On Kura Oncology, Inc. (KURA)Did Hedge Funds Make The Right Call On Kura Oncology, Inc. (KURA)
finance.yahoo.com - July 17 at 1:18 PM
Did Hedge Funds Make The Right Call On Kura Oncology, Inc. (KURA) ?Did Hedge Funds Make The Right Call On Kura Oncology, Inc. (KURA) ?
finance.yahoo.com - July 17 at 1:18 PM
Hedge Funds Aren’t Done Buying Kura Oncology, Inc. (KURA)Hedge Funds Aren’t Done Buying Kura Oncology, Inc. (KURA)
finance.yahoo.com - June 16 at 1:25 PM
Kura Oncology to Participate in JMP Securities Hematology & Oncology ForumKura Oncology to Participate in JMP Securities Hematology & Oncology Forum
finance.yahoo.com - June 11 at 12:30 PM
BRIEF-Kura Oncology Reports Overall Survival Data From Phase 2 Trial Of Tipifarnib In Hras Mutant Head And Neck Squamous Cell CarcinomaBRIEF-Kura Oncology Reports Overall Survival Data From Phase 2 Trial Of Tipifarnib In Hras Mutant Head And Neck Squamous Cell Carcinoma
www.reuters.com - May 29 at 1:34 PM
Kura Oncology Reports Overall Survival Data from Phase 2 Trial of Tipifarnib in HRAS Mutant Head and Neck Squamous Cell CarcinomaKura Oncology Reports Overall Survival Data from Phase 2 Trial of Tipifarnib in HRAS Mutant Head and Neck Squamous Cell Carcinoma
finance.yahoo.com - May 29 at 8:34 AM
Kura Oncology Announces Three Abstracts Accepted for Presentation at ASCO20 Virtual Scientific ProgramKura Oncology Announces Three Abstracts Accepted for Presentation at ASCO20 Virtual Scientific Program
finance.yahoo.com - May 13 at 9:09 PM
BRIEF-Kura Oncology Announces Closing Of Public OfferingBRIEF-Kura Oncology Announces Closing Of Public Offering
www.reuters.com - May 8 at 9:01 PM
Kura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional SharesKura Oncology Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
finance.yahoo.com - May 8 at 9:01 PM
Kura Oncology to Present at BofA Securities Virtual Health Care Conference 2020Kura Oncology to Present at BofA Securities Virtual Health Care Conference 2020
finance.yahoo.com - May 7 at 4:36 PM
Kura Oncology prices $125M public offering; shares -4%Kura Oncology prices $125M public offering; shares -4%
seekingalpha.com - May 6 at 10:16 AM
Kura Oncology Announces Pricing of $125 Million Public Offering of Common StockKura Oncology Announces Pricing of $125 Million Public Offering of Common Stock
finance.yahoo.com - May 6 at 10:16 AM
Kura Oncology, Inc. 2020 Q1 - Results - Earnings Call PresentationKura Oncology, Inc. 2020 Q1 - Results - Earnings Call Presentation
seekingalpha.com - May 5 at 5:07 PM
Kura Oncology Announces Commencement of Public Offering of Common StockKura Oncology Announces Commencement of Public Offering of Common Stock
finance.yahoo.com - May 5 at 5:07 PM
Kura Oncology, Inc. (KURA) Q1 2020 Earnings Call TranscriptKura Oncology, Inc. (KURA) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 5 at 12:06 PM
Edited Transcript of KURA earnings conference call or presentation 4-May-20 8:30pm GMTEdited Transcript of KURA earnings conference call or presentation 4-May-20 8:30pm GMT
finance.yahoo.com - May 5 at 7:04 AM
Kura Oncology, Inc. (KURA) CEO Troy Wilson on Q1 2020 Results - Earnings Call TranscriptKura Oncology, Inc. (KURA) CEO Troy Wilson on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 5 at 2:04 AM
This page was last updated on 12/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.